e-learning
resources
Vienna 2003
Monday 29.09.2003
COPD - basic mechanisms and therapy of acute exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microbiological and inflammatory patterns in severe exacerbated COPD
B. Lara, N. Soler, A. Carles, F. Xavier, B. Joan Ramon, F. Miquel, M. Marc, T. Antoni (Barcelona, Spain)
Source:
Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations
Session:
COPD - basic mechanisms and therapy of acute exacerbations
Session type:
Oral Presentation
Number:
2231
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Lara, N. Soler, A. Carles, F. Xavier, B. Joan Ramon, F. Miquel, M. Marc, T. Antoni (Barcelona, Spain). Microbiological and inflammatory patterns in severe exacerbated COPD. Eur Respir J 2003; 22: Suppl. 45, 2231
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Markers of severity and inflammatory profile during exacerbations of severe asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Determinants of heightened systemic inflammation at exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 115s
Year: 2006
Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology.
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Sputum rheology and bacteriology in stable and exacerbated chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Inflammatory changes, recovery and recurrence at COPD exacerbation
Source: Eur Respir J 2007; 29: 527-534
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept